Q2

Copy the MAL entry into your own directory
cp $CLIBD/monomers/m/MALcif ./

Then correctt it in your directory

And assign LIBIN ./MAL.cif

The program will read your corrected version and ignore the distributed one.


Q1

If you run REFMAC the GUI under review restraints, it will detect and make a LINK entry for you Then you will need to use the GUI task - merge monomer library to combine your corrected MAL with the new LINK

Run refmac again with XYZIN the output from "review restraints " task ( that will include a LINK record)
and it should/might! work..
Eleanor





Pioszak, Augie wrote:

Hello All,

I have two questions about refinement with Refmac5.

1. I have a protein structure that is C-terminally amidated. What is the best way to handle this?

I was trying to use the sketcher to create my own library definition for the modifed amino acid, but then I had issues with the modified amino acid not being covalently linked to the rest of the protein. I’m guessing there is a better way, such as creating a definition for just the additional NH2 group and telling refmac how to covalently link it to the last amino acid, but I’m not sure how to do this.

2. I have a structure with maltose in it. The refmac library definition for maltose has atoms “O1” and “O1,” mislabeled as Carbons. How can I correct this?

I know I can change it with the sketcher, but then it tells me the name MAL is already taken and I have to use another. I’d prefer to leave it as the standard MAL name.

Thanks for any help. I apologize if these issues have been covered before.

Augie

Augen Pioszak, Ph.D.

Postdoctoral Fellow

Laboratory of Structural Sciences

Van Andel Research Institute

333 Bostwick Ave. N.E.

Grand Rapids, MI 49503

phone: (616) 234-5399

email: [EMAIL PROTECTED] <mailto:[EMAIL PROTECTED]>

------------------------------------------------------------------------
**
**This email message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient(s) please contact the sender by reply email and destroy all copies of the original message. Thank you.**
------------------------------------------------------------------------

Reply via email to